Valuation for Castle Biosciences (id:6515 CSTL)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 127.57 |
|
|
| Forward P/E | -13.20 |
|
|
| Price to sales | 2.41 |
|
|
| Price to book | 1.70 |
|
|
| Enterprise to revenue | 1.62 |
|
|
| Enterprise to ebitda | 40.73 |
|
|